CVACX
Price
$18.81
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
VTSAX
Price
$144.14
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

CVACX vs VTSAX

Header iconCVACX vs VTSAX Comparison
Open Charts CVACX vs VTSAXBanner chart's image
Calamos Select Fund C
Price$18.81
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Vanguard Total Stock Mkt Idx Adm
Price$144.14
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
CVACX vs VTSAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CVACX vs. VTSAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVACX is a StrongBuy and VTSAX is a Buy.

FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 1.73T vs. CVACX (58.9M). VTSAX pays higher dividends than CVACX: VTSAX (1.35) vs CVACX (0.00). CVACX was incepted earlier than VTSAX: CVACX (23 years) vs VTSAX (24 years). CVACX is a more actively managed with annual turnover of: 55.00 vs. VTSAX (2.00). CVACX has a lower initial minimum investment than VTSAX: CVACX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 33.39 vs. CVACX (25.82). VTSAX return over 5 years is better than : 87.46 vs. CVACX (48.23).
CVACXVTSAXCVACX / VTSAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD24.90024.891100%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets58.9M1.73T0%
Annual Yield % from dividends0.001.35-
Returns for 1 year25.8233.3977%
Returns for 3 years5.9122.8226%
Returns for 5 years48.2387.4655%
Returns for 10 years37.80194.0719%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VERX50.580.83
+1.67%
Vertex
IT551.801.14
+0.21%
Gartner
PDFS31.88-0.95
-2.89%
PDF Solutions
KMDA6.06-0.21
-3.35%
Kamada Ltd
VRCA0.84-0.08
-8.37%
Verrica Pharmaceuticals